Mcdaniel Terry & CO Novartis Ag Transaction History

Mcdaniel Terry & CO

  • $1.22 Billion
  • Q2 2025

A detailed history of Mcdaniel Terry & CO transactions in Novartis Ag stock. As of the latest transaction made, Mcdaniel Terry & CO holds 3,500 shares of NVS stock, worth $462,875. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,500
Previous 3,895 10.14%
Holding current value
$462,875
Previous $434,000 2.53%
% of portfolio
0.03%
Previous 0.04%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 31, 2025
SELL
$101.96 - $121.01 $40,274 - $47,798
-395 Reduced 10.14%
3,500 $423,000
Q1 2025

Apr 24, 2025
SELL
$97.14 - $115.57 $4,371 - $5,200
-45 Reduced 1.14%
3,895 $434,000
Q4 2024

Feb 03, 2025
SELL
$96.78 - $117.18 $217,755 - $263,655
-2,250 Reduced 36.35%
3,940 $383,000
Q3 2024

Oct 23, 2024
BUY
$106.13 - $120.89 $39,268 - $44,729
370 Added 6.36%
6,190 $712,000
Q2 2024

Aug 05, 2024
SELL
$92.57 - $107.37 $15,181 - $17,608
-164 Reduced 2.74%
5,820 $620,000
Q1 2024

Apr 29, 2024
SELL
$95.27 - $108.47 $526,557 - $599,513
-5,527 Reduced 48.01%
5,984 $579,000
Q2 2023

Jul 21, 2023
SELL
$92.52 - $104.91 $1,110 - $1,258
-12 Reduced 0.1%
11,511 $1.16 Million
Q1 2023

May 05, 2023
SELL
$80.03 - $92.81 $14,005 - $16,241
-175 Reduced 1.5%
11,523 $1.06 Million
Q4 2022

Jan 23, 2023
SELL
$75.55 - $92.52 $44,574 - $54,586
-590 Reduced 4.8%
11,698 $1.06 Million
Q3 2022

Oct 06, 2022
SELL
$74.61 - $87.26 $35,290 - $41,273
-473 Reduced 3.71%
12,288 $934,000
Q2 2022

Jul 28, 2022
SELL
$80.52 - $93.75 $471,927 - $549,468
-5,861 Reduced 31.47%
12,761 $1.08 Million
Q1 2022

Apr 27, 2022
SELL
$80.11 - $90.62 $12 Million - $13.6 Million
-150,080 Reduced 88.96%
18,622 $1.63 Million
Q4 2021

Jan 20, 2022
SELL
$79.7 - $88.13 $3.49 Million - $3.86 Million
-43,773 Reduced 20.6%
168,702 $14.8 Million
Q3 2021

Dec 06, 2021
BUY
$81.78 - $95.14 $527,889 - $614,128
6,455 Added 3.13%
212,475 $17.4 Million
Q2 2021

Aug 11, 2021
BUY
$85.24 - $94.15 $243,871 - $269,363
2,861 Added 1.41%
206,020 $18.8 Million
Q1 2021

May 17, 2021
BUY
$83.5 - $98.47 $174,515 - $205,802
2,090 Added 1.04%
203,159 $17.4 Million
Q4 2020

Feb 12, 2021
BUY
$78.07 - $94.43 $310,796 - $375,925
3,981 Added 2.02%
201,069 $19 Million
Q3 2020

Nov 09, 2020
BUY
$82.14 - $91.0 $76,718 - $84,994
934 Added 0.48%
197,088 $17.1 Million
Q2 2020

Aug 13, 2020
SELL
$80.93 - $91.1 $409,991 - $461,512
-5,066 Reduced 2.52%
196,154 $17.1 Million
Q1 2020

May 08, 2020
BUY
$70.67 - $99.01 $431,157 - $604,060
6,101 Added 3.13%
201,220 $16.6 Million
Q4 2019

Feb 03, 2020
SELL
$84.35 - $95.37 $147,106 - $166,325
-1,744 Reduced 0.89%
195,119 $18.5 Million
Q3 2019

Nov 07, 2019
SELL
$85.54 - $94.26 $204,868 - $225,752
-2,395 Reduced 1.2%
196,863 $17.1 Million
Q2 2019

Aug 12, 2019
BUY
$75.4 - $92.8 $103,147 - $126,950
1,368 Added 0.69%
199,258 $18.2 Million
Q1 2019

May 09, 2019
BUY
$75.32 - $86.15 $56,791 - $64,957
754 Added 0.38%
197,890 $0
Q4 2018

Feb 07, 2019
SELL
$73.66 - $82.02 $49,425 - $55,035
-671 Reduced 0.34%
197,136 $16.9 Million
Q3 2018

Nov 13, 2018
BUY
$66.94 - $77.43 $45,318 - $52,420
677 Added 0.34%
197,807 $17 Million
Q2 2018

Aug 13, 2018
BUY
$64.91 - $73.36 $130,988 - $148,040
2,018 Added 1.03%
197,130 $14.9 Million
Q1 2018

May 11, 2018
SELL
$70.39 - $84.15 $31,253 - $37,362
-444 Reduced 0.23%
195,112 $15.8 Million
Q4 2017

Feb 09, 2018
SELL
$72.33 - $77.64 $40,432 - $43,400
-559 Reduced 0.29%
195,556 $16.4 Million
Q3 2017

Nov 13, 2017
SELL
$74.14 - $77.27 $411,477 - $428,848
-5,550 Reduced 2.75%
196,115 $16.8 Million
Q2 2017

Aug 10, 2017
BUY
N/A
201,665
201,665 $16.8 Million

Others Institutions Holding NVS

# of Institutions
1,561
Shares Held
136M
Call Options Held
1.72M
Put Options Held
1.7M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $284B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Mcdaniel Terry & CO Portfolio

Follow Mcdaniel Terry & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcdaniel Terry & CO, based on Form 13F filings with the SEC.

News

Stay updated on Mcdaniel Terry & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email